|
Volumn 48, Issue 17, 2013, Pages 10-12
|
The larger implications of the Novartis-Glivec judgment
|
Author keywords
[No Author keywords available]
|
Indexed keywords
|
EID: 84876817537
PISSN: 00129976
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (9)
|
References (2)
|